Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 3
2018 3
2019 1
2020 3
2021 7
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options.
Skowron MA, Kotthoff M, Bremmer F, Ruhnke K, Parmaksiz F, Richter A, Küffer S, Reuter-Jessen K, Pauls S, Stefanski A, Ströbel P, Stühler K, Nettersheim D. Skowron MA, et al. Mol Med. 2023 Mar 29;29(1):40. doi: 10.1186/s10020-023-00636-3. Mol Med. 2023. PMID: 36991316 Free PMC article.
Molecular and epigenetic pathogenesis of germ cell tumors.
Müller MR, Skowron MA, Albers P, Nettersheim D. Müller MR, et al. Among authors: skowron ma. Asian J Urol. 2021 Apr;8(2):144-154. doi: 10.1016/j.ajur.2020.05.009. Epub 2020 May 30. Asian J Urol. 2021. PMID: 33996469 Free PMC article. Review.
CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partners.
Söhngen C, Thomas DJ, Skowron MA, Bremmer F, Eckstein M, Stefanski A, Driessen MD, Wakileh GA, Stühler K, Altevogt P, Theodorescu D, Klapdor R, Schambach A, Nettersheim D. Söhngen C, et al. Among authors: skowron ma. FEBS J. 2023 Oct;290(20):4864-4876. doi: 10.1111/febs.16880. Epub 2023 Jun 26. FEBS J. 2023. PMID: 37254618
Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies.
Burmeister A, Stephan A, Alves Avelar LA, Müller MR, Seiwert A, Höfmann S, Fischer F, Torres-Gomez H, Hoffmann MJ, Niegisch G, Bremmer F, Petzsch P, Köhrer K, Albers P, Kurz T, Skowron MA, Nettersheim D. Burmeister A, et al. Among authors: skowron ma. Mol Cancer Ther. 2022 Nov 3;21(11):1674-1688. doi: 10.1158/1535-7163.MCT-22-0207. Mol Cancer Ther. 2022. PMID: 35999659 Free PMC article.
The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours.
Wruck W, Bremmer F, Kotthoff M, Fichtner A, Skowron MA, Schönberger S, Calaminus G, Vokuhl C, Pfister D, Heidenreich A, Albers P, Adjaye J, Nettersheim D. Wruck W, et al. Among authors: skowron ma. J Cell Mol Med. 2021 Feb;25(3):1394-1405. doi: 10.1111/jcmm.16222. Epub 2021 Jan 14. J Cell Mol Med. 2021. PMID: 33448076 Free PMC article.
The signal transducer CD24 suppresses the germ cell program and promotes an ectodermal rather than mesodermal cell fate in embryonal carcinomas.
Skowron MA, Becker TK, Kurz L, Jostes S, Bremmer F, Fronhoffs F, Funke K, Wakileh GA, Müller MR, Burmeister A, Lenz T, Stefanski A, Stühler K, Petzsch P, Köhrer K, Altevogt P, Albers P, Kristiansen G, Schorle H, Nettersheim D. Skowron MA, et al. Mol Oncol. 2022 Feb;16(4):982-1008. doi: 10.1002/1878-0261.13066. Epub 2021 Aug 2. Mol Oncol. 2022. PMID: 34293822 Free PMC article.
26 results